APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hip and Joint Supplement for Pet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Hip and Joint Supplement for Pet Market Outlook and Growth Opportunities 2026

6 January 2026208 pages

Choose your research edition.

Industry ResearchHip and Joint Supplement for Pet Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Hip and Joint Supplement for Pet Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Hip and Joint Supplement for Pet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hip and Joint Supplement for Pet Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Hip and Joint Supplement for Pet Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Hip and Joint Supplement for Pet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Hip and Joint Supplement for Pet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hip and Joint Supplement for Pet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hip and Joint Supplement for Pet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Hip and Joint Supplement for Pet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Hip and Joint Supplement for Pet market include Mars, Nestle Purina, EverRoot, Milk-Bone, Blue Buffalo, VetIQ, JPK Nutri, maxxipaws and Unicharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hip and Joint Supplement for Pet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hip and Joint Supplement for Pet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hip and Joint Supplement for Pet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hip and Joint Supplement for Pet market size, projected growth trends, production technologies, key applications, and end-use industries.

Hip and Joint Supplement for Pet Segment by Company

Mars

Nestle Purina

EverRoot

Milk-Bone

Blue Buffalo

VetIQ

JPK Nutri

maxxipaws

Unicharm

OSCAR Pet Foods

Affinity Petcare

MoonShine

Yantai China Pet Foods

GREENIES

Wagg

Petpal Tech

DogKind

Pet Treats

Pet Chews

Hip and Joint Supplement for Pet Segment by Type

Biscuits

Soft Treats

Chewable Tablets

Others

Hip and Joint Supplement for Pet Segment by Application

Dogs

Cats

Others

Hip and Joint Supplement for Pet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hip and Joint Supplement for Pet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hip and Joint Supplement for Pet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hip and Joint Supplement for Pet significant trends, drivers, influence factors in global and regions.

6. To analyze Hip and Joint Supplement for Pet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hip and Joint Supplement for Pet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hip and Joint Supplement for Pet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hip and Joint Supplement for Pet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hip and Joint Supplement for Pet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hip and Joint Supplement for Pet industry.

Chapter 3: Detailed analysis of Hip and Joint Supplement for Pet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hip and Joint Supplement for Pet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hip and Joint Supplement for Pet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hip and Joint Supplement for Pet Industry Trends Table 2. Hip and Joint Supplement for Pet Industry Drivers Table 3. Hip and Joint Supplement for Pet Industry Opportunities and Challenges Table 4. Hip and Joint Supplement for Pet Industry Restraints Table 5. Global Hip and Joint Supplement for Pet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hip and Joint Supplement for Pet Revenue Share by Company (2021-2026) Table 7. Global Hip and Joint Supplement for Pet Sales Volume by Company (t) & (2021-2026) Table 8. Global Hip and Joint Supplement for Pet Sales Volume Share by Company (2021-2026) Table 9. Global Hip and Joint Supplement for Pet Average Price (USD/t) of Company (2021-2026) Table 10. Global Hip and Joint Supplement for Pet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hip and Joint Supplement for Pet Key Company Manufacturing Base & Headquarters Table 12. Global Hip and Joint Supplement for Pet Company, Product Type & Application Table 13. Global Hip and Joint Supplement for Pet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hip and Joint Supplement for Pet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Biscuits Table 18. Significant Companies of Soft Treats Table 19. Significant Companies of Chewable Tablets Table 20. Significant Companies of Others Table 21. Global Hip and Joint Supplement for Pet Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Hip and Joint Supplement for Pet Sales Volume by Type (2021-2026) & (t) Table 23. Global Hip and Joint Supplement for Pet Sales Volume by Type (2027-2032) & (t) Table 24. Global Hip and Joint Supplement for Pet Sales Volume Share by Type (2021-2026) Table 25. Global Hip and Joint Supplement for Pet Sales Volume Share by Type (2027-2032) Table 26. Global Hip and Joint Supplement for Pet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Hip and Joint Supplement for Pet Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Hip and Joint Supplement for Pet Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Hip and Joint Supplement for Pet Sales Value Share by Type (2021-2026) Table 30. Global Hip and Joint Supplement for Pet Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Dogs Table 32. Significant Companies of Cats Table 33. Significant Companies of Others Table 34. Global Hip and Joint Supplement for Pet Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Hip and Joint Supplement for Pet Sales Volume by Application (2021-2026) & (t) Table 36. Global Hip and Joint Supplement for Pet Sales Volume by Application (2027-2032) & (t) Table 37. Global Hip and Joint Supplement for Pet Sales Volume Share by Application (2021-2026) Table 38. Global Hip and Joint Supplement for Pet Sales Volume Share by Application (2027-2032) Table 39. Global Hip and Joint Supplement for Pet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Hip and Joint Supplement for Pet Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Hip and Joint Supplement for Pet Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Hip and Joint Supplement for Pet Sales Value Share by Application (2021-2026) Table 43. Global Hip and Joint Supplement for Pet Sales Value Share by Application (2027-2032) Table 44. Global Hip and Joint Supplement for Pet Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Hip and Joint Supplement for Pet Sales by Region (2021-2026) & (t) Table 46. Global Hip and Joint Supplement for Pet Sales Market Share by Region (2021-2026) Table 47. Global Hip and Joint Supplement for Pet Sales by Region (2027-2032) & (t) Table 48. Global Hip and Joint Supplement for Pet Sales Market Share by Region (2027-2032) Table 49. Global Hip and Joint Supplement for Pet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Hip and Joint Supplement for Pet Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Hip and Joint Supplement for Pet Sales Value Share by Region (2021-2026) Table 52. Global Hip and Joint Supplement for Pet Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Hip and Joint Supplement for Pet Sales Value Share by Region (2027-2032) Table 54. Global Hip and Joint Supplement for Pet Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Hip and Joint Supplement for Pet Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Hip and Joint Supplement for Pet Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Hip and Joint Supplement for Pet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hip and Joint Supplement for Pet Sales by Country (2021-2026) & (t) Table 59. Global Hip and Joint Supplement for Pet Sales Market Share by Country (2021-2026) Table 60. Global Hip and Joint Supplement for Pet Sales by Country (2027-2032) & (t) Table 61. Global Hip and Joint Supplement for Pet Sales Market Share by Country (2027-2032) Table 62. Global Hip and Joint Supplement for Pet Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Hip and Joint Supplement for Pet Sales Value Market Share by Country (2021-2026) Table 64. Global Hip and Joint Supplement for Pet Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Hip and Joint Supplement for Pet Sales Value Market Share by Country (2027-2032) Table 66. Mars Company Information Table 67. Mars Business Overview Table 68. Mars Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. Mars Hip and Joint Supplement for Pet Product Portfolio Table 70. Mars Recent Development Table 71. Nestle Purina Company Information Table 72. Nestle Purina Business Overview Table 73. Nestle Purina Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Nestle Purina Hip and Joint Supplement for Pet Product Portfolio Table 75. Nestle Purina Recent Development Table 76. EverRoot Company Information Table 77. EverRoot Business Overview Table 78. EverRoot Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. EverRoot Hip and Joint Supplement for Pet Product Portfolio Table 80. EverRoot Recent Development Table 81. Milk-Bone Company Information Table 82. Milk-Bone Business Overview Table 83. Milk-Bone Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Milk-Bone Hip and Joint Supplement for Pet Product Portfolio Table 85. Milk-Bone Recent Development Table 86. Blue Buffalo Company Information Table 87. Blue Buffalo Business Overview Table 88. Blue Buffalo Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Blue Buffalo Hip and Joint Supplement for Pet Product Portfolio Table 90. Blue Buffalo Recent Development Table 91. VetIQ Company Information Table 92. VetIQ Business Overview Table 93. VetIQ Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. VetIQ Hip and Joint Supplement for Pet Product Portfolio Table 95. VetIQ Recent Development Table 96. JPK Nutri Company Information Table 97. JPK Nutri Business Overview Table 98. JPK Nutri Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. JPK Nutri Hip and Joint Supplement for Pet Product Portfolio Table 100. JPK Nutri Recent Development Table 101. maxxipaws Company Information Table 102. maxxipaws Business Overview Table 103. maxxipaws Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. maxxipaws Hip and Joint Supplement for Pet Product Portfolio Table 105. maxxipaws Recent Development Table 106. Unicharm Company Information Table 107. Unicharm Business Overview Table 108. Unicharm Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Unicharm Hip and Joint Supplement for Pet Product Portfolio Table 110. Unicharm Recent Development Table 111. OSCAR Pet Foods Company Information Table 112. OSCAR Pet Foods Business Overview Table 113. OSCAR Pet Foods Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. OSCAR Pet Foods Hip and Joint Supplement for Pet Product Portfolio Table 115. OSCAR Pet Foods Recent Development Table 116. Affinity Petcare Company Information Table 117. Affinity Petcare Business Overview Table 118. Affinity Petcare Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Affinity Petcare Hip and Joint Supplement for Pet Product Portfolio Table 120. Affinity Petcare Recent Development Table 121. MoonShine Company Information Table 122. MoonShine Business Overview Table 123. MoonShine Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. MoonShine Hip and Joint Supplement for Pet Product Portfolio Table 125. MoonShine Recent Development Table 126. Yantai China Pet Foods Company Information Table 127. Yantai China Pet Foods Business Overview Table 128. Yantai China Pet Foods Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Yantai China Pet Foods Hip and Joint Supplement for Pet Product Portfolio Table 130. Yantai China Pet Foods Recent Development Table 131. GREENIES Company Information Table 132. GREENIES Business Overview Table 133. GREENIES Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. GREENIES Hip and Joint Supplement for Pet Product Portfolio Table 135. GREENIES Recent Development Table 136. Wagg Company Information Table 137. Wagg Business Overview Table 138. Wagg Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Wagg Hip and Joint Supplement for Pet Product Portfolio Table 140. Wagg Recent Development Table 141. Petpal Tech Company Information Table 142. Petpal Tech Business Overview Table 143. Petpal Tech Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Petpal Tech Hip and Joint Supplement for Pet Product Portfolio Table 145. Petpal Tech Recent Development Table 146. DogKind Company Information Table 147. DogKind Business Overview Table 148. DogKind Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. DogKind Hip and Joint Supplement for Pet Product Portfolio Table 150. DogKind Recent Development Table 151. Pet Treats Company Information Table 152. Pet Treats Business Overview Table 153. Pet Treats Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 154. Pet Treats Hip and Joint Supplement for Pet Product Portfolio Table 155. Pet Treats Recent Development Table 156. Pet Chews Company Information Table 157. Pet Chews Business Overview Table 158. Pet Chews Hip and Joint Supplement for Pet Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 159. Pet Chews Hip and Joint Supplement for Pet Product Portfolio Table 160. Pet Chews Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Hip and Joint Supplement for Pet Distributors List Table 164. Hip and Joint Supplement for Pet Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Hip and Joint Supplement for Pet Product Image Figure 2. Global Hip and Joint Supplement for Pet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hip and Joint Supplement for Pet Sales (2021-2032) & (t) Figure 5. Global Hip and Joint Supplement for Pet Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Hip and Joint Supplement for Pet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Biscuits Image Figure 10. Soft Treats Image Figure 11. Chewable Tablets Image Figure 12. Others Image Figure 13. Global Hip and Joint Supplement for Pet Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Hip and Joint Supplement for Pet Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Hip and Joint Supplement for Pet Sales Volume Share by Type (2021-2032) Figure 16. Global Hip and Joint Supplement for Pet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Hip and Joint Supplement for Pet Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Hip and Joint Supplement for Pet Sales Value Share by Type (2021-2032) Figure 19. Dogs Image Figure 20. Cats Image Figure 21. Others Image Figure 22. Global Hip and Joint Supplement for Pet Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Hip and Joint Supplement for Pet Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Hip and Joint Supplement for Pet Sales Volume Share by Application (2021-2032) Figure 25. Global Hip and Joint Supplement for Pet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Hip and Joint Supplement for Pet Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Hip and Joint Supplement for Pet Sales Value Share by Application (2021-2032) Figure 28. Global Hip and Joint Supplement for Pet Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Hip and Joint Supplement for Pet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Hip and Joint Supplement for Pet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Hip and Joint Supplement for Pet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 33. North America Hip and Joint Supplement for Pet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Hip and Joint Supplement for Pet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Hip and Joint Supplement for Pet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 39. South America Hip and Joint Supplement for Pet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Hip and Joint Supplement for Pet Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Hip and Joint Supplement for Pet Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Hip and Joint Supplement for Pet Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Hip and Joint Supplement for Pet Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Biscuits
  • Soft Treats
  • Chewable Tablets
  • Others
Applications
  • Dogs
  • Cats
  • Others
Companies covered
  • Mars
  • Nestle Purina
  • EverRoot
  • Milk-Bone
  • Blue Buffalo
  • VetIQ
  • JPK Nutri
  • maxxipaws
  • Unicharm
  • OSCAR Pet Foods
  • Affinity Petcare
  • MoonShine
  • Yantai China Pet Foods
  • GREENIES
  • Wagg
  • Petpal Tech
  • DogKind
  • Pet Treats
  • Pet Chews

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hip and Joint Supplement for Pet Sales Value (2021-2032)
  4. 1.2.2 Global Hip and Joint Supplement for Pet Sales Volume (2021-2032)
  5. 1.2.3 Global Hip and Joint Supplement for Pet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hip and Joint Supplement for Pet Market Dynamics
  1. 2.1 Hip and Joint Supplement for Pet Industry Trends
  2. 2.2 Hip and Joint Supplement for Pet Industry Drivers
  3. 2.3 Hip and Joint Supplement for Pet Industry Opportunities and Challenges
  4. 2.4 Hip and Joint Supplement for Pet Industry Restraints
3 Hip and Joint Supplement for Pet Market by Company
  1. 3.1 Global Hip and Joint Supplement for Pet Company Revenue Ranking in 2025
  2. 3.2 Global Hip and Joint Supplement for Pet Revenue by Company (2021-2026)
  3. 3.3 Global Hip and Joint Supplement for Pet Sales Volume by Company (2021-2026)
  4. 3.4 Global Hip and Joint Supplement for Pet Average Price by Company (2021-2026)
  5. 3.5 Global Hip and Joint Supplement for Pet Company Ranking (2024-2026)
  6. 3.6 Global Hip and Joint Supplement for Pet Company Manufacturing Base and Headquarters
  7. 3.7 Global Hip and Joint Supplement for Pet Company Product Type and Application
  8. 3.8 Global Hip and Joint Supplement for Pet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hip and Joint Supplement for Pet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hip and Joint Supplement for Pet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hip and Joint Supplement for Pet Market by Type
  1. 4.1 Hip and Joint Supplement for Pet Type Introduction
  2. 4.1.1 Biscuits
  3. 4.1.2 Soft Treats
  4. 4.1.3 Chewable Tablets
  5. 4.1.4 Others
  6. 4.2 Global Hip and Joint Supplement for Pet Sales Volume by Type
  7. 4.2.1 Global Hip and Joint Supplement for Pet Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Hip and Joint Supplement for Pet Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Hip and Joint Supplement for Pet Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Hip and Joint Supplement for Pet Sales Value by Type
  11. 4.3.1 Global Hip and Joint Supplement for Pet Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Hip and Joint Supplement for Pet Sales Value by Type (2021-2032)
  13. 4.3.3 Global Hip and Joint Supplement for Pet Sales Value Share by Type (2021-2032)
5 Hip and Joint Supplement for Pet Market by Application
  1. 5.1 Hip and Joint Supplement for Pet Application Introduction
  2. 5.1.1 Dogs
  3. 5.1.2 Cats
  4. 5.1.3 Others
  5. 5.2 Global Hip and Joint Supplement for Pet Sales Volume by Application
  6. 5.2.1 Global Hip and Joint Supplement for Pet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hip and Joint Supplement for Pet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Hip and Joint Supplement for Pet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Hip and Joint Supplement for Pet Sales Value by Application
  10. 5.3.1 Global Hip and Joint Supplement for Pet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hip and Joint Supplement for Pet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Hip and Joint Supplement for Pet Sales Value Share by Application (2021-2032)
6 Hip and Joint Supplement for Pet Regional Sales and Value Analysis
  1. 6.1 Global Hip and Joint Supplement for Pet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hip and Joint Supplement for Pet Sales by Region (2021-2032)
  3. 6.2.1 Global Hip and Joint Supplement for Pet Sales by Region: 2021-2026
  4. 6.2.2 Global Hip and Joint Supplement for Pet Sales by Region (2027-2032)
  5. 6.3 Global Hip and Joint Supplement for Pet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hip and Joint Supplement for Pet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hip and Joint Supplement for Pet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hip and Joint Supplement for Pet Sales Value by Region (2027-2032)
  9. 6.5 Global Hip and Joint Supplement for Pet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hip and Joint Supplement for Pet Sales Value (2021-2032)
  12. 6.6.2 North America Hip and Joint Supplement for Pet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hip and Joint Supplement for Pet Sales Value (2021-2032)
  15. 6.7.2 Europe Hip and Joint Supplement for Pet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hip and Joint Supplement for Pet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hip and Joint Supplement for Pet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hip and Joint Supplement for Pet Sales Value (2021-2032)
  21. 6.9.2 South America Hip and Joint Supplement for Pet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hip and Joint Supplement for Pet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hip and Joint Supplement for Pet Sales Value Share by Country, 2025 VS 2032
7 Hip and Joint Supplement for Pet Country-level Sales and Value Analysis
  1. 7.1 Global Hip and Joint Supplement for Pet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hip and Joint Supplement for Pet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hip and Joint Supplement for Pet Sales by Country (2021-2032)
  4. 7.3.1 Global Hip and Joint Supplement for Pet Sales by Country (2021-2026)
  5. 7.3.2 Global Hip and Joint Supplement for Pet Sales by Country (2027-2032)
  6. 7.4 Global Hip and Joint Supplement for Pet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hip and Joint Supplement for Pet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hip and Joint Supplement for Pet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hip and Joint Supplement for Pet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hip and Joint Supplement for Pet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hip and Joint Supplement for Pet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mars
  2. 8.1.1 Mars Company Information
  3. 8.1.2 Mars Business Overview
  4. 8.1.3 Mars Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mars Hip and Joint Supplement for Pet Product Portfolio
  6. 8.1.5 Mars Recent Developments
  7. 8.2 Nestle Purina
  8. 8.2.1 Nestle Purina Company Information
  9. 8.2.2 Nestle Purina Business Overview
  10. 8.2.3 Nestle Purina Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nestle Purina Hip and Joint Supplement for Pet Product Portfolio
  12. 8.2.5 Nestle Purina Recent Developments
  13. 8.3 EverRoot
  14. 8.3.1 EverRoot Company Information
  15. 8.3.2 EverRoot Business Overview
  16. 8.3.3 EverRoot Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 EverRoot Hip and Joint Supplement for Pet Product Portfolio
  18. 8.3.5 EverRoot Recent Developments
  19. 8.4 Milk-Bone
  20. 8.4.1 Milk-Bone Company Information
  21. 8.4.2 Milk-Bone Business Overview
  22. 8.4.3 Milk-Bone Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Milk-Bone Hip and Joint Supplement for Pet Product Portfolio
  24. 8.4.5 Milk-Bone Recent Developments
  25. 8.5 Blue Buffalo
  26. 8.5.1 Blue Buffalo Company Information
  27. 8.5.2 Blue Buffalo Business Overview
  28. 8.5.3 Blue Buffalo Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Blue Buffalo Hip and Joint Supplement for Pet Product Portfolio
  30. 8.5.5 Blue Buffalo Recent Developments
  31. 8.6 VetIQ
  32. 8.6.1 VetIQ Company Information
  33. 8.6.2 VetIQ Business Overview
  34. 8.6.3 VetIQ Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 VetIQ Hip and Joint Supplement for Pet Product Portfolio
  36. 8.6.5 VetIQ Recent Developments
  37. 8.7 JPK Nutri
  38. 8.7.1 JPK Nutri Company Information
  39. 8.7.2 JPK Nutri Business Overview
  40. 8.7.3 JPK Nutri Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 JPK Nutri Hip and Joint Supplement for Pet Product Portfolio
  42. 8.7.5 JPK Nutri Recent Developments
  43. 8.8 maxxipaws
  44. 8.8.1 maxxipaws Company Information
  45. 8.8.2 maxxipaws Business Overview
  46. 8.8.3 maxxipaws Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 maxxipaws Hip and Joint Supplement for Pet Product Portfolio
  48. 8.8.5 maxxipaws Recent Developments
  49. 8.9 Unicharm
  50. 8.9.1 Unicharm Company Information
  51. 8.9.2 Unicharm Business Overview
  52. 8.9.3 Unicharm Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Unicharm Hip and Joint Supplement for Pet Product Portfolio
  54. 8.9.5 Unicharm Recent Developments
  55. 8.10 OSCAR Pet Foods
  56. 8.10.1 OSCAR Pet Foods Company Information
  57. 8.10.2 OSCAR Pet Foods Business Overview
  58. 8.10.3 OSCAR Pet Foods Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 OSCAR Pet Foods Hip and Joint Supplement for Pet Product Portfolio
  60. 8.10.5 OSCAR Pet Foods Recent Developments
  61. 8.11 Affinity Petcare
  62. 8.11.1 Affinity Petcare Company Information
  63. 8.11.2 Affinity Petcare Business Overview
  64. 8.11.3 Affinity Petcare Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Affinity Petcare Hip and Joint Supplement for Pet Product Portfolio
  66. 8.11.5 Affinity Petcare Recent Developments
  67. 8.12 MoonShine
  68. 8.12.1 MoonShine Company Information
  69. 8.12.2 MoonShine Business Overview
  70. 8.12.3 MoonShine Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 MoonShine Hip and Joint Supplement for Pet Product Portfolio
  72. 8.12.5 MoonShine Recent Developments
  73. 8.13 Yantai China Pet Foods
  74. 8.13.1 Yantai China Pet Foods Company Information
  75. 8.13.2 Yantai China Pet Foods Business Overview
  76. 8.13.3 Yantai China Pet Foods Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Yantai China Pet Foods Hip and Joint Supplement for Pet Product Portfolio
  78. 8.13.5 Yantai China Pet Foods Recent Developments
  79. 8.14 GREENIES
  80. 8.14.1 GREENIES Company Information
  81. 8.14.2 GREENIES Business Overview
  82. 8.14.3 GREENIES Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GREENIES Hip and Joint Supplement for Pet Product Portfolio
  84. 8.14.5 GREENIES Recent Developments
  85. 8.15 Wagg
  86. 8.15.1 Wagg Company Information
  87. 8.15.2 Wagg Business Overview
  88. 8.15.3 Wagg Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Wagg Hip and Joint Supplement for Pet Product Portfolio
  90. 8.15.5 Wagg Recent Developments
  91. 8.16 Petpal Tech
  92. 8.16.1 Petpal Tech Company Information
  93. 8.16.2 Petpal Tech Business Overview
  94. 8.16.3 Petpal Tech Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Petpal Tech Hip and Joint Supplement for Pet Product Portfolio
  96. 8.16.5 Petpal Tech Recent Developments
  97. 8.17 DogKind
  98. 8.17.1 DogKind Company Information
  99. 8.17.2 DogKind Business Overview
  100. 8.17.3 DogKind Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 DogKind Hip and Joint Supplement for Pet Product Portfolio
  102. 8.17.5 DogKind Recent Developments
  103. 8.18 Pet Treats
  104. 8.18.1 Pet Treats Company Information
  105. 8.18.2 Pet Treats Business Overview
  106. 8.18.3 Pet Treats Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Pet Treats Hip and Joint Supplement for Pet Product Portfolio
  108. 8.18.5 Pet Treats Recent Developments
  109. 8.19 Pet Chews
  110. 8.19.1 Pet Chews Company Information
  111. 8.19.2 Pet Chews Business Overview
  112. 8.19.3 Pet Chews Hip and Joint Supplement for Pet Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Pet Chews Hip and Joint Supplement for Pet Product Portfolio
  114. 8.19.5 Pet Chews Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hip and Joint Supplement for Pet Value Chain Analysis
  2. 9.1.1 Hip and Joint Supplement for Pet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hip and Joint Supplement for Pet Sales Mode & Process
  6. 9.2 Hip and Joint Supplement for Pet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hip and Joint Supplement for Pet Distributors
  9. 9.2.3 Hip and Joint Supplement for Pet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst